About Mervyn Turner
Form D filings for Spinogenix from 2023 to 2024 list Mervyn Turner as director.
Form D filings also name Mervyn Turner as a director at Amydis.
Mervyn Turner first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Mervyn Turner in the role, so the role may have started earlier or lasted longer.
Spinogenix, Inc.
Director
2023 – 2024 · Los Angeles, CA
Develops experimental medicines for people with neurological and psychiatric conditions.
Key Colleagues at Startups
The people Mervyn Turner works with at each company, as listed on that company's latest Form D.
Spinogenix, Inc. · Form D, Jun 21, 2024
DA
Dan Albosta
Executive officer
SS
Stella Sarraf
Executive officer and director
PV
Peter Vanderklish
Executive officer
Jerre Stead
Director
Amydis, Inc. · Form D, Dec 28, 2023
CA
Christine Aylward
Director
SS
Stella Sarraf
CEO and director
JK
James Khodabakhsh
Director
Jerre Stead
Director
JC
Jack Thrift, CPA
Executive officer